This effect is reversible with PI3K/mTOR inhibitors, indicating that the PTEN-PI3K/Akt-mTOR pathway is a potential mechanism through which BMI1 exacerbates myocardial fibrosis and worsens cardiac function after myocardial infarction [107]. Here, BMI1 is linked to Myocardial fibrosis.